Article info

Download PDFPDF

Correspondence on ‘Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case–control study’ by Potere et al
Free

Authors

  1. Correspondence to Dr Leo Buckley, Brigham and Women's Hospital, Boston, MA 02115-6195, USA; lfbuckley{at}bwh.harvard.edu
View Full Text

Citation

Buckley L
Correspondence on ‘Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case–control study’ by Potere et al

Publication history

  • Received July 24, 2020
  • Accepted July 26, 2020
  • First published September 1, 2020.
Online issue publication 
September 12, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.